Last December, a government task force laid out recommendations for legalizing recreational marijuana along with a roadmap to accomplish it by the end of 2018 or early 2019 at the latest.
It’s no surprise that the news boosted stock prices for several of the publicly traded companies licensed to produce medical marijuana. Canopy Growth Corp. (TSX:WEED), owner of core marijuana brands Tweed and Bedrocan, is currently trading around $10 a share; it was trading below $4 as recently as September.